OZVONTI
Dead / Abandoned — Abandoned — no statement of use filed (as of 17 Nov 2025)
What this means for you
This application is over — abandoned 17 Nov 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97060091
- Mark type
- Stylized text
- Filed
- 05 Oct 2021
- Published for opposition
- 16 Aug 2022
- Abandoned
- 17 Nov 2025
- Attorney of record
- Tim Burgdorf
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer; pharmaceuticals for oncological treatment
Owner
- Spectrum Pharmaceuticals, Inc., Irvine, CA, US
- Spectrum Pharmaceuticals, Inc., Irvine, CA, US
Prosecution history
- 17 Nov 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 17 Nov 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 16 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Apr 2025 — SOU EXTENSION 5 GRANTED
- 11 Apr 2025 — SOU EXTENSION 5 FILED
- 05 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Feb 2025 — SOU EXTENSION 4 GRANTED
- 11 Oct 2024 — SOU EXTENSION 4 FILED
- 04 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Nov 2024 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 12 Nov 2024 — NOTICE OF REVIVAL - E-MAILED
- 12 Nov 2024 — PETITION TO REVIVE-GRANTED
- 12 Nov 2024 — TEAS PETITION TO REVIVE RECEIVED
- 11 Nov 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Nov 2024 — ABANDONMENT - NO USE STATEMENT FILED